Fish By-Products: A Source of Enzymes to Generate Circular Bioactive Hydrolysates

Molecules. 2023 Jan 24;28(3):1155. doi: 10.3390/molecules28031155.

Abstract

Fish viscera are usually discarded as waste, causing environmental problems, or as low-value by-products. This study describes a self-sufficient and zero waste approach to obtain enzymes and protein hydrolysates from fish by-products. Firstly, recovery steps of viscera enzymatic extract were applied, and the resulting raw extract was stable at a pH range of 8-9 and at temperatures between 40 and 50 °C. The application of the extracted enzymes and alcalase on fish by-products hydrolysis was also determined. The selected conditions for the enzymatic hydrolysis were 10% (E/S) for 6 h using viscera enzymatic extract and 3% (E/S) for 2 h using alcalase. Fish protein hydrolysates (FPH) proved to have a notable antioxidant capacity with similar activity, ~11 mg ascorbic acid/g dry extract (ABTS assay) and ~150 mg Trolox/g dry extract (ORAC assay). FPH were also able to inhibit the angiotensin-converting enzyme, however, alcalase hydrolysates revealed a higher antihypertensive potential, IC50 of 101 µg of protein/mL. In general, FPH obtained by both enzymes systems maintained these bioactivities after the passage throughout a simulated gastrointestinal tract. The hydrolysates also displayed important technological properties, namely oil absorption capacity (~1 g oil/g sample) and emulsifying property (~40%). Therefore, it will be conceivable to use fish by-products based on a circular economy approach to generate added value compounds for animal and human nutrition.

Keywords: bioactive peptides; protein hydrolysis; technological properties; viscera.

MeSH terms

  • Animals
  • Antihypertensive Agents*
  • Antioxidants / chemistry
  • Antioxidants / pharmacology
  • Fishes / metabolism
  • Humans
  • Hydrolysis
  • Protein Hydrolysates* / chemistry
  • Subtilisins / metabolism

Substances

  • Protein Hydrolysates
  • Antihypertensive Agents
  • Antioxidants
  • Subtilisins

Grants and funding

This work was supported by National Funds from the project MOREPEP (POCI-01-0247-FEDER-017638) funded by Fundo Europeu de Desenvolvimento Regional (FEDER), under Programa Operacional Competitividade e Internacionalização (POCI), and from FCT—Fundação para a Ciência e a Tecnologia through the project UIDB/50016/2020.